- Home
- CXT vs ADMA Comparison
CXT vs ADMA Comparison
Compare CXT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXT
- ADMA
- Stock Information
- Founded
- CXT 1855
- ADMA 2004
- Country
- CXT United States
- ADMA United States
- Employees
- CXT N/A
- ADMA N/A
- Industry
- CXT Office Equipment/Supplies/Services
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CXT Industrials
- ADMA Health Care
- Exchange
- CXT Nasdaq
- ADMA Nasdaq
- Market Cap
- CXT 3.9B
- ADMA 3.5B
- IPO Year
- CXT N/A
- ADMA N/A
- Fundamental
- Price
- CXT $66.40
- ADMA $15.25
- Analyst Decision
- CXT Buy
- ADMA Strong Buy
- Analyst Count
- CXT 4
- ADMA 3
- Target Price
- CXT $75.75
- ADMA $27.67
- AVG Volume (30 Days)
- CXT 388.0K
- ADMA 3.5M
- Earning Date
- CXT 11-05-2025
- ADMA 11-07-2025
- Dividend Yield
- CXT 1.03%
- ADMA N/A
- EPS Growth
- CXT N/A
- ADMA 469.09
- EPS
- CXT 2.61
- ADMA 0.85
- Revenue
- CXT $1,537,300,000.00
- ADMA $474,174,000.00
- Revenue This Year
- CXT $9.09
- ADMA $21.08
- Revenue Next Year
- CXT $7.64
- ADMA $25.98
- P/E Ratio
- CXT $25.30
- ADMA $17.96
- Revenue Growth
- CXT 10.28
- ADMA 43.58
- 52 Week Low
- CXT $41.54
- ADMA $13.50
- 52 Week High
- CXT $69.00
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- CXT 54.09
- ADMA 50.85
- Support Level
- CXT $65.59
- ADMA $14.35
- Resistance Level
- CXT $68.54
- ADMA $16.08
- Average True Range (ATR)
- CXT 1.74
- ADMA 0.54
- MACD
- CXT -0.33
- ADMA 0.17
- Stochastic Oscillator
- CXT 48.60
- ADMA 63.27
About CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.